Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Poliwoda

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Cytogenetic studies in renal cell carcinoma patients receiving low-dose recombinant interleukin-2-based immunotherapyS Duensing, E van den Berg-de Ruiter, S Störkel, et al.
Annals of Hematology|February 1, 1992
Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL)M Freund, S Wunsch-Zeddies, M Schäfers, et al.
Annals of Hematology|August 1, 1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancerC Bokemeyer, H J Schmoll, B Metzner, et al.
Molecular Biotherapy|September 1, 1990
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experienceH Kirchner, A Körfer, P A Palmer, et al.
Transfusion Science|November 3, 1996
Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donorsJ G Kadar, L Arseniev, K Schnitger, et al.
Cancer|July 1, 1993
Single-agent carboplatinum for advanced seminoma. A phase II studyH J Schmoll, A Harstrick, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adultsA Harstrick, C Bokemeyer, H J Schmoll, et al.
Blood|October 1, 1995
Combined transplantation of allogeneic bone marrow and CD34+ blood cellsH Link, L Arseniev, O Bähre, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences]M Freund, P Heussner, F Hild, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]G Hübner, H Link, P Schönrock-Nabulsi, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Cytogenetic studies in renal cell carcinoma patients receiving low-dose recombinant interleukin-2-based immunotherapyS Duensing, E van den Berg-de Ruiter, S Störkel, et al.
Annals of Hematology|February 1, 1992
Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL)M Freund, S Wunsch-Zeddies, M Schäfers, et al.
Annals of Hematology|August 1, 1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancerC Bokemeyer, H J Schmoll, B Metzner, et al.
Molecular Biotherapy|September 1, 1990
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experienceH Kirchner, A Körfer, P A Palmer, et al.
Transfusion Science|November 3, 1996
Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donorsJ G Kadar, L Arseniev, K Schnitger, et al.
Cancer|July 1, 1993
Single-agent carboplatinum for advanced seminoma. A phase II studyH J Schmoll, A Harstrick, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adultsA Harstrick, C Bokemeyer, H J Schmoll, et al.
Blood|October 1, 1995
Combined transplantation of allogeneic bone marrow and CD34+ blood cellsH Link, L Arseniev, O Bähre, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences]M Freund, P Heussner, F Hild, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]G Hübner, H Link, P Schönrock-Nabulsi, et al.
Pageof 10